Boston Scientific Says Unlikely to Meet 2026 Forecast After Cyberattack Disruption

insurancejournal.com · 2026-09-08

Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year 2026 sales and adjusted profit forecasts,

TickrTrends take: Abbott Laboratories operates in the Healthcare sector where operational disruptions can have material impacts on financial performance and investor confidence. Boston Scientific's recent cyberattack and subsequent withdrawal of 2026 guidance illustrates how unexpected events can pressure companies in this space to revise outlooks, a factor that valuation models must account for when assessing healthcare equipment and pharmaceutical manufacturers. Given TickrTrends' current undervalued assessment of ABT, investors should monitor whether Abbott faces similar operational risks or guidance adjustments that could influence whether the undervaluation thesis remains intact.

Read the full story at insurancejournal.com →